semaglutide hemodialysis pharmacokinetics in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open‐label study - Vanek - 2024 - Diabetes, Obesity and Metabolism Semaglutide-Mediated Remodeling of Adipose Tissue

Extended appetite suppression can blunt the bodys internal feedback systems, making it difficult to accurately sense when nourishment is needed or when intake is sufficient

Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate

GI side effects typically range from mild to moderate in severity, often occur temporarily, commonly beginning during the period of initiation and dose escalation and typically resolving after reaching the maintenance dose

Some inhibitors face challenges in in vivo testing because of their poor specificity

These foods add volume to meals without overwhelming your reduced stomach capacity

More often than not, patients reveal something unexpected